The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials

@article{Su2019TheEA,
  title={The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials},
  author={S. Su and N. He and P. Men and C. Song and S. Zhai},
  journal={Osteoporosis International},
  year={2019},
  volume={30},
  pages={1175-1186}
}
  • S. Su, N. He, +2 authors S. Zhai
  • Published 2019
  • Medicine
  • Osteoporosis International
  • SummaryIn our systematic review and meta-analysis, we comprehensively evaluated menatetrenone in the management of osteoporosis. We found that menatetrenone decreased the ratio of undercarboxylated osteocalcin to osteocalcin (ucOC/OC) and improved lumbar BMD compared with placebo based on the 18 studies assessed. However, its benefit in fracture risk control was uncertain.IntroductionWe performed a systematic review and meta-analysis of the efficacy and safety of menatetrenone in managing… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 61 REFERENCES
    Vitamin K2 (Menatetrenone) Effectively Prevents Fractures and Sustains Lumbar Bone Mineral Density in Osteoporosis
    • 393
    • Highly Influential
    Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
    • 92
    • Highly Influential
    Vitamin K2 Therapy for Postmenopausal Osteoporosis
    • 50
    • PDF